AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35306189 — intervention group
Group type: COMPARATOR
Intervention: Educational photo book about intravenous placement
Number of subjects: 134
Study 33887343 — intervention group
Group type: EXPERIMENTAL
Intervention: Pacing ON (DDD‐CLS mode)
Number of subjects: 103
Study 33887343 — intervention group
Group type: COMPARATOR
Intervention: Pacing OFF (ODO mode)
Number of subjects: 103
Study 33201144 — intervention group
Group type: EXPERIMENTAL
Intervention: Multilayered polyurethane foam dressing applied within 24 hours of hospital admission
Number of subjects: 68
Study 33201144 — intervention group
Group type: COMPARATOR
Intervention: Standard preventive pressure injury care
Number of subjects: 68
Study 36207226 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive sacral neuromodulation (SNM) for 12 weeks
Number of subjects: 59
Study 36207226 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment for 12 weeks
Number of subjects: 59
Study 34134758 — intervention group
Group type: EXPERIMENTAL
Intervention: Enriched Garden (EG)
Number of subjects: 120
Study 34134758 — intervention group
Group type: COMPARATOR
Intervention: Conventional Sensory Garden (CSG)
Number of subjects: 120
Study 34134758 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 120
Study 36397219 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose acupuncture (3 times each chemotherapy cycle for a total of 9 times)
Number of subjects: 58
Study 36397219 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose acupuncture (7 times each chemotherapy cycle for a total of 21 times)
Number of subjects: 58
Study 36397219 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional chemotherapy and antiemetic treatment)
Number of subjects: 58
Study 32900325 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone
Number of subjects: 1513
Study 32900325 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1513
Study 34281312 — intervention group
Group type: EXPERIMENTAL
Intervention: CGF-WP (White Part)
Number of subjects: 4
Study 34281312 — intervention group
Group type: EXPERIMENTAL
Intervention: CGF-BC (Buffy Coat)
Number of subjects: 4
Study 34281312 — intervention group
Group type: COMPARATOR
Intervention: CTR (Control - natural healing)
Number of subjects: 4
Study 34339562 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group 1 (age-targeted messages)
Number of subjects: 825
Study 34339562 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group 2 (age-targeted messages)
Number of subjects: 825
Study 34339562 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 825
Study 33229455 — intervention group
Group type: EXPERIMENTAL
Intervention: Eculizumab
Number of subjects: 117
Study 33229455 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study 35732399 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal paclitaxel monotherapy, administered through a peritoneal port-a-cath (PAC) system, with 8-16 weekly cycles.
Number of subjects: 0
Study 33406254 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher sleep fragmentation index
Number of subjects: 615
Study 33406254 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater wake after sleep onset
Number of subjects: 615
Study 33406254 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower percent sleep
Number of subjects: 615
Study 32275690 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon α1b nebulization
Number of subjects: 0
Study 34952973 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided saline enema with intestinal fluid drained after 15 minutes of intestinal pressure maintenance (intervention group)
Number of subjects: 231
Study 34952973 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound-guided saline enema with intestinal fluid drained immediately (control group)
Number of subjects: 231
Study 34302324 — intervention group
Group type: EXPERIMENTAL
Intervention: Anlotinib (12 mg orally once daily for 14 days every 3 weeks)
Number of subjects: 82
Study 34302324 — intervention group
Group type: COMPARATOR
Intervention: Placebo (analogue capsule orally once daily for 14 days every 3 weeks)
Number of subjects: 82
Study 34302324 — intervention group
Group type: EXPERIMENTAL
Intervention: Anlotinib
Number of subjects: 82
Study 34266468 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral economic implementation strategies (nudges) delivered through electronic medical record (EMR) messages to patients, clinicians, or both.
Number of subjects: 0
Study 34266468 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral economic implementation strategies (nudges)
Number of subjects: 0
Study 34266468 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-structured interviews
Number of subjects: 0
Study 35621222 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 13885
Study 35621222 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 13885
Study 36306479 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab 200 mg once every 3 weeks for 35 cycles
Number of subjects: 1274
Study 36306479 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (carboplatin + paclitaxel or pemetrexed) for 4-6 cycles with optional maintenance pemetrexed
Number of subjects: 1274
Study 36306479 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-course pembrolizumab
Number of subjects: 1274
Study 36306479 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab after 35 cycles
Number of subjects: 1274
Study 34990498 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous paracetamol 15 mg/kg before treatment (preemptive group, n = 35)
Number of subjects: 70
Study 34990498 — intervention group
Group type: COMPARATOR
Intervention: Control group received intravenous paracetamol 15 mg/kg at the end of treatment (control group, n = 35)
Number of subjects: 70
Study 32634820 — intervention group
Group type: EXPERIMENTAL
Intervention: Reports on infant body composition available to clinicians
Number of subjects: 50
Study 32634820 — intervention group
Group type: COMPARATOR
Intervention: No reports on infant body composition available to clinicians (Control)
Number of subjects: 50
Study 33660001 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapist-supervised pelvic floor muscle (PFM) training
Number of subjects: 103
Study 33660001 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care - handout)
Number of subjects: 103
Study 33507592 — intervention group
Group type: EXPERIMENTAL
Intervention: 750 mg/kg/d of standardized extract of Nasturtium officinale (SENO)
Number of subjects: 34
Study 33507592 — intervention group
Group type: COMPARATOR
Intervention: 750 mg/kg/d of placebo
Number of subjects: 34
Study 35998251 — intervention group
Group type: EXPERIMENTAL
Intervention: Rest-Pause (RP): 3 × 16 repetitions at 75% 1RM
Number of subjects: 27
Study 35998251 — intervention group
Group type: EXPERIMENTAL
Intervention: Drop-Set (DS): 3 × 10 repetitions at 75% with 6 additional repetitions at 55% 1RM
Number of subjects: 27
Study 35998251 — intervention group
Group type: COMPARATOR
Intervention: Traditional (TRAD): 4 × 12 repetitions at 70% 1RM
Number of subjects: 27
Study 33693639 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized orientation programme inclusive of environmental cues
Number of subjects: 40
Study 32159257 — intervention group
Group type: EXPERIMENTAL
Intervention: Garlic supplement (500 mg, 2 tablets daily for 8 weeks)
Number of subjects: 70
Study 32159257 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2 tablets daily for 8 weeks)
Number of subjects: 70
Study 34582088 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy using non-ablative fractional laser and intralesional triamcinolone injection
Number of subjects: 64
Study 34582088 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-treatment)
Number of subjects: 64
Study 33704569 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser therapy (n = 19)
Number of subjects: 75
Study 33704569 — intervention group
Group type: EXPERIMENTAL
Intervention: Nd:YAG laser therapy (n = 15)
Number of subjects: 75
Study 33704569 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG + Nd:YAG combination therapy (n = 20)
Number of subjects: 75
Study 33704569 — intervention group
Group type: COMPARATOR
Intervention: Scalpel excision (control group, n = 21)
Number of subjects: 75
Study 33704569 — intervention group
Group type: EXPERIMENTAL
Intervention: All HLLT groups (Er:YAG, Nd:YAG, Er:YAG + Nd:YAG)
Number of subjects: 75
Study 33704569 — intervention group
Group type: EXPERIMENTAL
Intervention: All study groups (including control)
Number of subjects: 75
Study 32445434 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin
Number of subjects: 0
Study 32445434 — intervention group
Group type: COMPARATOR
Intervention: No prophylaxis
Number of subjects: 0
Study 36102261 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective PCI after COURAGE trial (2007)
Number of subjects: 1245802
Study 36102261 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective PCI after ORBITA trial (2017)
Number of subjects: 1245802
Study 36102261 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective PCI without angina symptoms
Number of subjects: 1245802
Study 36102261 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective PCI rates per year
Number of subjects: 1245802
Study 36102261 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective PCI rates per 100,000 population
Number of subjects: 1245802
Study 33749762 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients aged >70 years
Number of subjects: 5922
Study 33749762 — intervention group
Group type: COMPARATOR
Intervention: Patients aged ≤70 years
Number of subjects: 5922
Study 33749762 — intervention group
Group type: EXPERIMENTAL
Intervention: All patients
Number of subjects: 5922
Study 33749762 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients aged >70 years vs ≤70 years
Number of subjects: 5922
Study 33749762 — intervention group
Group type: EXPERIMENTAL
Intervention: Age >70 years
Number of subjects: 5922
Study 33749762 — intervention group
Group type: EXPERIMENTAL
Intervention: Age groups comparison
Number of subjects: 5922
Study 35113140 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D viewing group
Number of subjects: 46
Study 35113140 — intervention group
Group type: COMPARATOR
Intervention: 2D viewing group
Number of subjects: 46
Study 37842338 — intervention group
Group type: EXPERIMENTAL
Intervention: Cash grant of 500 USD
Number of subjects: 2177
Study 37842338 — intervention group
Group type: EXPERIMENTAL
Intervention: Cash grant of 500 USD (males)
Number of subjects: 2177
Study 37842338 — intervention group
Group type: EXPERIMENTAL
Intervention: Cash grant of 500 USD (females)
Number of subjects: 2177
Study 37842338 — intervention group
Group type: EXPERIMENTAL
Intervention: Mentorship
Number of subjects: 2177
Study 32335288 — intervention group
Group type: EXPERIMENTAL
Intervention: Take a Break intervention including Motivational Messages, text message Challenge Quizzes, Goal-setting with tobacco treatment specialist, Coping Mini-Games apps, Recognition and Rewards for participation during a 3-week challenge.
Number of subjects: 0
Study 32335288 — intervention group
Group type: COMPARATOR
Intervention: Brief Nicotine Replacement Therapy (NRT) sampling and daily smoking assessment text messages for three weeks.
Number of subjects: 0
Study 36307161 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracoscopic left atrial appendage closure (LAAC)
Number of subjects: 186
Study 36307161 — intervention group
Group type: COMPARATOR
Intervention: Novel oral anticoagulants (NOACs)
Number of subjects: 186
Study 34676440 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (20 mg, oral)
Number of subjects: 102
Study 36208361 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Check-Up (FCU)
Number of subjects: 361
Study 36208361 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 361
Study 33755227 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorella water extract (CWE)
Number of subjects: 44
Study 33755227 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 32234652 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MD) plus probiotics (Bifidobacterium longum BB536, Lactobacillus rhamnosus HN001) for 4 months (n = 16)
Number of subjects: 34
Study 32234652 — intervention group
Group type: COMPARATOR
Intervention: Mediterranean diet (MD) alone for 4 months (n = 18)
Number of subjects: 34
Study 35821019 — intervention group
Group type: EXPERIMENTAL
Intervention: nab-paclitaxel/cisplatin (AP)
Number of subjects: 254
Study 35821019 — intervention group
Group type: COMPARATOR
Intervention: gemcitabine/cisplatin (GP)
Number of subjects: 254
Study 33216002 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-based cognitive behavioral therapy (TCBT); n=17 at 3 months and n=13 at 12 months
Number of subjects: 34
Study 33216002 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based cognitive behavioral therapy (WCBT); n=17 at 3 months and n=12 at 12 months
Number of subjects: 34
Study 35659264 — intervention group
Group type: EXPERIMENTAL
Intervention: Time Out consultation (TOC) with the general practitioner (GP) and follow-up by a home care oncology nurse (HON)
Number of subjects: 154
Study 35659264 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 154
Study 32058444 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-hour repositioning combined with a viscoelastic foam mattress
Number of subjects: 1204
Study 32058444 — intervention group
Group type: COMPARATOR
Intervention: 2-hour repositioning combined with a powered air pressure redistribution mattress
Number of subjects: 1204
Study 34000119 — intervention group
Group type: EXPERIMENTAL
Intervention: Complicated Grief Treatment (CGT) with placebo
Number of subjects: 395
Study 34000119 — intervention group
Group type: EXPERIMENTAL
Intervention: CGT plus citalopram
Number of subjects: 395
Study 34000119 — intervention group
Group type: COMPARATOR
Intervention: Citalopram
Number of subjects: 395
Study 34000119 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 395
Study 33248586 — intervention group
Group type: EXPERIMENTAL
Intervention: Feed formulation with 60% CP soybean meal (SBM)
Number of subjects: 120
Study 33248586 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased feed crumble particle size with fewer fines in starter feed
Number of subjects: 120
Study 33248586 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary enzyme cocktail (Rovabio Advance)
Number of subjects: 120
Study 33248586 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced feed fines without dietary enzyme cocktail
Number of subjects: 120
Study 35647715 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple-exemplar training, prompting, and social reinforcement
Number of subjects: 25
Study 35647715 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 25
Study 33256621 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab and maintenance Mycophenolate mofetil (1200 mg/m2 per day starting 3 months after Rituximab)
Number of subjects: 100
Study 33256621 — intervention group
Group type: COMPARATOR
Intervention: Repeated courses of prophylactic Rituximab (administered at 0, 8 and 16 months if B cell count normalizes)
Number of subjects: 100
Study 33256621 — intervention group
Group type: COMPARATOR
Intervention: Both groups (A and B)
Number of subjects: 100
Study 32295049 — intervention group
Group type: EXPERIMENTAL
Intervention: Salt iodization policy
Number of subjects: 18864
Study 32295049 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional status measured by BMI
Number of subjects: 18864
Study 36325128 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose pistachios (3.0 oz/d; PH)
Number of subjects: 27
Study 36325128 — intervention group
Group type: COMPARATOR
Intervention: Control (water only)
Number of subjects: 27
Study 36325128 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose pistachios (1.5 oz/d; PL)
Number of subjects: 27
Study 36325128 — intervention group
Group type: EXPERIMENTAL
Intervention: Pistachios (both doses)
Number of subjects: 27
Study 32045501 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose baclofen (75 mg/day)
Number of subjects: 42
Study 32045501 — intervention group
Group type: COMPARATOR
Intervention: Low-dose baclofen (30 mg/day)
Number of subjects: 42
Study 32045501 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 34134947 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatherapy (AT)
Number of subjects: 160
Study 34134947 — intervention group
Group type: EXPERIMENTAL
Intervention: Music Therapy (MT)
Number of subjects: 160
Study 34134947 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination Therapy (CT)
Number of subjects: 160
Study 34134947 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 160
Study 32034474 — intervention group
Group type: EXPERIMENTAL
Intervention: Self‐made drainage tubes with a small diameter (outer diameter 2.0 mm, inner diameter 1.0 mm)
Number of subjects: 153
Study 32034474 — intervention group
Group type: COMPARATOR
Intervention: No. 8 tubes
Number of subjects: 153
Study 35637140 — intervention group
Group type: EXPERIMENTAL
Intervention: Active retrieval (writing down the steps from memory for 15 minutes)
Number of subjects: 50
Study 35637140 — intervention group
Group type: COMPARATOR
Intervention: Passive studying (reading the steps)
Number of subjects: 50
Study 33451603 — intervention group
Group type: COMPARATOR
Intervention: Surgical staples
Number of subjects: 232
Study 33451603 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcuticular suture
Number of subjects: 232
Study 32532222 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated classification algorithm
Number of subjects: 102
Study 32532222 — intervention group
Group type: COMPARATOR
Intervention: Neurologist classification
Number of subjects: 102
Study 36243123 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% dextrose PrT
Number of subjects: 60
Study 36243123 — intervention group
Group type: EXPERIMENTAL
Intervention: 15% dextrose PrT
Number of subjects: 60
Study 36243123 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline injections
Number of subjects: 60
Study 33573767 — intervention group
Group type: EXPERIMENTAL
Intervention: Nudge strategies embedded within an enhanced invitation
Number of subjects: 88
Study 33573767 — intervention group
Group type: COMPARATOR
Intervention: Generic invitation
Number of subjects: 88
Study 33278138 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of grafts in frontal sinus drill-outs
Number of subjects: 0
Study 32194148 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiazolidinediones
Number of subjects: 41871
Study 32194148 — intervention group
Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 41871
Study 32194148 — intervention group
Group type: EXPERIMENTAL
Intervention: PERR Pairwise estimates for thiazolidinediones
Number of subjects: 41871
Study 32194148 — intervention group
Group type: COMPARATOR
Intervention: ADOPT trial
Number of subjects: 41871
Study 36379883 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA) 1g before incision, followed by 125mg/h infusion
Number of subjects: 218
Study 36379883 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 218
Study 36379883 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA)
Number of subjects: 218
Study 34475164 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher relationship satisfaction
Number of subjects: 547
Study 32378726 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity arm resistance training (HIT)
Number of subjects: 43
Study 32378726 — intervention group
Group type: COMPARATOR
Intervention: Low-intensity arm resistance training (LIT)
Number of subjects: 43
Study 32378726 — intervention group
Group type: EXPERIMENTAL
Intervention: Both HIT and LIT
Number of subjects: 43
Study 35119235 — intervention group
Group type: EXPERIMENTAL
Intervention: 980nm diode laser
Number of subjects: 60
Study 35119235 — intervention group
Group type: COMPARATOR
Intervention: Cold scalpel
Number of subjects: 60
Study 34164367 — intervention group
Group type: EXPERIMENTAL
Intervention: Short nap + normal indoor light (100 lx, 4,000 K at eye level)
Number of subjects: 17
Study 34164367 — intervention group
Group type: COMPARATOR
Intervention: No nap + normal indoor light
Number of subjects: 17
Study 34164367 — intervention group
Group type: EXPERIMENTAL
Intervention: No nap + blue-enriched bright light (1,000 lx, 6,500 K at eye level)
Number of subjects: 17
Study 34448219 — intervention group
Group type: EXPERIMENTAL
Intervention: Single 6-mm implant with a cantilever (ONE-C)
Number of subjects: 36
Study 34448219 — intervention group
Group type: COMPARATOR
Intervention: Two 6-mm implants (TWO)
Number of subjects: 36
Study 35932397 — intervention group
Group type: EXPERIMENTAL
Intervention: SHUTi-OASIS (Internet-delivered cognitive behavioral therapy for insomnia)
Number of subjects: 311
Study 35932397 — intervention group
Group type: COMPARATOR
Intervention: Patient Education (control group)
Number of subjects: 311
Study 35932397 — intervention group
Group type: EXPERIMENTAL
Intervention: SHUTi-OASIS
Number of subjects: 311
Study 35932397 — intervention group
Group type: COMPARATOR
Intervention: Patient Education
Number of subjects: 311
Study 32959588 — intervention group
Group type: EXPERIMENTAL
Intervention: Wentong acupuncture
Number of subjects: 128
Study 32959588 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D calcium chewable tablets (0.6 g, once a day) and calcitriol capsules (0.25 μg, three times a day)
Number of subjects: 128
Study 33258162 — intervention group
Group type: EXPERIMENTAL
Intervention: HPMC-based films with 0.1% DL-α-tocopherol acetate (VE)
Number of subjects: 0
Study 33258162 — intervention group
Group type: EXPERIMENTAL
Intervention: SPI-based films with 0.25% oleic acid and 0.1% VE
Number of subjects: 0
Study 33258162 — intervention group
Group type: EXPERIMENTAL
Intervention: HPMC films
Number of subjects: 0
Study 33258162 — intervention group
Group type: EXPERIMENTAL
Intervention: SPI-based pouch after 60 days of storage at 35 °C
Number of subjects: 0
Study 33258162 — intervention group
Group type: EXPERIMENTAL
Intervention: HPMC/2% CNC film
Number of subjects: 0
Study 32515888 — intervention group
Group type: EXPERIMENTAL
Intervention: Year-long telephone-delivered lifestyle support by health professionals
Number of subjects: 2607
Study 32515888 — intervention group
Group type: COMPARATOR
Intervention: Control group (no lifestyle intervention)
Number of subjects: 2607